Swedish Heart & Vascular Institute

Swedish Heart & Vascular Institute

Philanthropic support of the Swedish Heart & Vascular Institute empowers our physicians and staff to provide the leading-edge research and treatment to change lives.

From providing holistic care to patients with a dangerous and all-too-common arrhythmia to supporting next-generation research that could stop heart attacks before they start, supporters like you make the difference.

Patient Care & Support

Navigation Program for Advance Cardiovascular Care
As if it’s not overwhelming enough just knowing you’re about to undergo major surgery, there are a number of intimidating steps to take before the procedure begins. The Navigation Program helps patients from diagnosis to the day they go home—answering their questions and ensuring they have a partner in their recovery.

Advanced Cardiac Support
The John L. Locke Jr. Advanced Cardiac Support Program for heart helps provide leading-edge treatments to our patients through the training and collaboration of a multidisciplinary staff of pharmacists, dieticians, social workers and heart failure physicians.

Heart & Vascular Research

Rising Stars Research Program
Led by John L. Petersen II, M.D., the Rising Stars Research Program has developed a first-of-their-kind model of the heart to perform angioscopies and angioplasties on both intact hearts and isolated coronary arteries. Think of these perfusion models as the cardiac-surgery equivalent of a flight simulator to, ultimately, refine angioplasty best practices.

Innovative Treatment

Swedish Comprehensive AFib Network (SCAN)
AFib is the most common arrhythmia in the United States, and its prevalence grows every year. It can be treated with medications or ablation, a procedure that involves scarring tissue inside the heart to disrupt faulty electrical signals that cause the irregular heartbeat.

SCAN helps patients to coordinate their care with multiple specialists, including sleep medicine physicians, neurologists and nutritionists—an approach that has been shown to drastically reduce the chances of patients with AFib being admitted to the hospital.

Contact Us

For questions or to learn more, please contact:

Libby SchoenbornLibby Manthei
Philanthropy Officer
[email protected]